Duke Pathology has implemented a new platform in the My Duke Health patient portal that distills complex medical terminology into easy-to-understand plain language explanations and diagrams.

From breast cancer to rare pediatric diseases, federally funded Duke biomedical research has helped Duke staff and faculty and their families.

Doctors are taking a closer look at how obesity affects breast cancer and whether popular weight loss drugs might fit into future breast cancer prevention and treatment strategies.

E. Harvey Estes, Jr., MD, a pioneering physician, educator, and leader whose contributions to Duke have left an enduring legacy, passed away on October 16, 2025, after having celebrated his 100th birthday this past May.   

Researchers at Duke University School of Medicine have identified two enzymes that can produce a key ingredient in antibiotics, antivirals, and cancer drugs without the use of toxic chemicals.

Despite leading the world in health spending, the U.S. lags in preventing premature deaths, performing worse than expected for its wealth.

A three-step study — lab experiments with zebrafish, computer simulation, and robotic testing — reveal how closely the brain and body work together to guide movement based on what we see.

Early findings from research led by Katie Holliday, PhD, assistant professor in family medicine and community health, show that fear of racism and discrimination keep some women from exercising in their communities. The study also found that Latinas were more concerned about being harassed by men while exercising in public spaces than white or Black women.

Duke researchers are using artificial intelligence to design new ways to deliver drugs via nanoparticles, improving the precision and effectiveness of treatment.

Carole Ryan’s enduring love for her daughter, Suzanne Ryan Driver, has fueled more than $4 million in support for brain tumor research at Duke Health, including a newly announced $2.5 million planned gift. Through the Suzanne Ryan Driver Brain Tumor Research Fund, Carole’s generosity continues to drive innovation and hope for patients battling high-grade gliomas.